RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY

The work is devoted to the development of nasal spray containing naltrexone hydrochloride. Naltrexone in doses of 3-5 mg/day acts on the opioid growth factor receptor (OGFr) and toll-like receptor 4 that makes it promising for use in the complex therapy of autoimmune diseases and conditions caused b...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Y. M. Domnina, S. A. Kedik, V. V. Suslov, E. A. Shnyak
Formato:	Artigo
Idioma:	Russo
Publicado em:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
coleção:	Разработка и регистрация лекарственных средств
Assuntos:	naltrexone hydrochloride low dose naltrexone nasal spray polymers viscosity
Acesso em linha:	https://www.pharmjournal.ru/jour/article/view/635
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!